Medical devices, healthcare technology and the business of care
PMA SUPPLEMENT · P030036/S162

MEDTRONIC SELECTSECURE LEAD MODEL 3830

Medtronic Cardiac Rhythm Disease Management · Decision date Oct 16, 2026

MEDTECHLEDGER EXPLANATIONP030036/S162

What did the FDA decide?

Medtronic Cardiac Rhythm Disease Management received an FDA decision recorded as OK30 on 2026-10-16 for supplement S162 to PMA P030036, covering the Model 3830 SelectSecure lead, a drug-eluting permanent right ventricular or right atrial pacemaker electrode (product code NVN, cardiovascular). The supplement is a 30-day notice filed under the reason "Process Change - Manufacturer/Sterilizer/Packager/Supplier," and the stated purpose is to modify the manufacturing method for the inner assembly stringing process.

Because S162 is a supplement, P030036 remains the original approval and this notice is not a new approval of the whole system. The record identifies which process step changes—assembly of the inner assembly during stringing—but does not specify the equipment, parameter limits, validation data, or the original approved method, and the OK30 entry alone does not independently establish safety or clinical effectiveness.

FDA approval order statement

modify the manufacturing method for the inner assembly stringing process
Regulatory pathway
PMA supplement
Supplement type
30-Day Notice
Clinical specialty
Cardiovascular
Decision date
Oct 16, 2026
FDA change category
Process Change - Manufacturer/Sterilizer/Packager/Supplier

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
P030036/S162
Regulatory pathway
PMA supplement
Product code
NVN
Decision code
OK30
Decision date
Oct 16, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Drug eluting permanent right ventricular (RV) or right atrial (RA) pacemaker electrodes.

Product code
NVN
FDA device class
3

For the original device and its historical approval scope, see PMA P030036. Subsequent supplements may change the device or its indications.

FDA decision timeline

  1. P030036 · Original PMA

    MEDTRONIC SELECTSECURE LEAD MODEL 3830

  2. P030036/S162 received

    Application receipt date recorded by FDA.

  3. P030036/S162 · FDA decision

    30-Day Notice

Timeline entries are records held by MedtechLedger for P030036. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P030036

Product / regulatory recordCompanyPathwayDecision dateSource
Medtronic Cardiac Rhythm Disease ManagementPMA approvalAug 3, 2005FDA

Explore the linked device profile

Other records with product code NVN

Product / regulatory recordCompanyPathwayDecision dateSource
ABBOTT MEDICALPMA supplementOct 9, 2026FDA
ABBOTT MEDICALPMA approvalJun 20, 1997FDA

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Medtronic Cardiac Rhythm Disease Management

Headquarters
Not reported
Brand website
medtronic.com
FDA applicant address
8200 Coral Sea St. N.E, Mounds View, MN, 55112

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records